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We studied the application of pulsed laser ablation (pLA) for particle size reduction in non‑steroidal 
anti‑inflammatory drugs (NSAIDs). Grinding of the poorly water‑soluble NSAID crystallites can 
considerably increase their solubility and bioavailability, thereby the necessary doses can be reduced 
significantly. We used tablets of ibuprofen, niflumic acid and meloxicam as targets. Nanosecond laser 
pulses were applied at various wavelengths (KrF excimer laser, λ = 248 nm, FWHM = 18 ns and Nd:YAG 
laser, λ1 = 532 nm/λ2 = 1064 nm, FWHM = 6 ns) and at various fluences. FTIR and Raman spectra showed 
that the chemical compositions of the drugs had not changed during ablation at 532 nm and 1064 nm 
laser wavelengths. The size distribution of the ablated products was established using two types of 
particle size analyzers (SMPS and OPC) having complementary measuring ranges. The mean size of 
the drug crystallites decreased from the initial 30–80 µm to the submicron to nanometer range. For a 
better understanding of the ablation mechanism we made several investigations (SEM, Ellipsometry, 
Fast photography) and some model calculations. We have established that PLA offers a chemical‑free 
and simple method for the size reduction of poorly water‑soluble drugs and a possible new way for 
pharmaceutical drug preformulation for nasal administration.
Many widely applied non-steroidal anti-inflammatory drugs (NSAIDs) are poorly water-soluble and have rela-
tively low bioavailability. Consequently, improving their solubility and dissolution rate would provide a great 
opportunity to lower the required doses and reduce the risk of side effects. To address these challenges research 
teams have developed several techniques such as crystal engineering, salt formation, solid dispersion, amorphiza-
tion and particle size reduction, but these procedures often require complex laboratory  work1–6.
Particle size reduction is one of the most popular and efficient methods to produce micro- or nanoparticles 
in order to increase the specific surface area and thereby improve the dissolution rate of poorly soluble drugs. In 
this case the dissolution rate is directly proportional to the specific surface area, therefore the dissolution rate, 
the saturation concentration and the bioavailability of the drugs can all be  enhanced7. The two conventional and 
straightforward size reduction methods are comminution (grinding, milling) and spray drying. Both methods 
apply mechanical stress for the disaggregation of the active compound, but the smallest attainable sizes still 
remain in the micrometer  regime8,9. Advanced methods can reach the upper part of sub-micrometer ranges but 
the procedures involved are sometimes complicated or need additional materials, which makes it more difficult 
to produce particles in this size  range10–13.
Pulsed laser ablation (PLA) is a well-known technique for nanoparticle generation in case of inorganic materi-
als. During PLA a high-energy pulsed laser beam is focused onto the target, which results in micro-explosions 
close to the surface, and the ejection of particles. Ablated products are collected for further  analysis14–17. It has 
already been shown that PLA/PLD is suitable for the size reduction of pharmaceutical particles without causing 
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any chemical decomposition. In recent years, researchers have also started to use lasers for particle size reduction 
in drugs in liquid environment (PLAL)18–23.
In this work, three NSAIDs (ibuprofen, meloxicam and niflumic acid) with different chemical structures but 
similar solubility, dissociation constant, particle size and crystallinity were selected as targets to study the effect 
of a high-energy pulsed laser beam on the chemical degradation and particle size distribution of the ablated drug 
particles. Being selective cyclooxygenase (COX-2) inhibitors, these model drugs are used in acute pain therapy 
where a basic requirement is rapid absorption through the gastric  mucosa24. Since these drugs have a weak acidic 
character, their solubility in gastric juice (pH = 1.2) is very poor. On the other hand, ablated particles dissolve 
faster and can produce rapid analgesic effect.
Our aim was to study the validity of the PLA method for particle size reduction in different drugs with low 
dissolution rates, in ambient gas at normal pressure. Ibuprofen, meloxicam and niflumic acid are frequently used, 
poorly water-soluble NSAIDs, representing three different molecular derivatives. We also wanted to explore the 
mechanism of PLA when drug targets with different thermal and optical properties are ablated under various 
experimental conditions. To cover the UV–VIS–IR regime with ablating laser wavelengths, a KrF excimer laser 
(λ = 248 nm) and a Nd:YAG laser system (λ1 = 1064 nm, λ2 = 532 nm) were used. We adjusted laser fluences at each 
wavelength to the optical and mechanical properties of the target materials. Ablated products were collected at 
normal ambient pressure using  N2 gas flow. We studied the chemical composition and particle size distribution 
of the ablated particles, the optical absorption of the target drugs and made fast photography measurements 
too. Our motivation was to show that PLA, a simple and chemical-free particle grinding method, has a great 
potential in pharmaceutics. Laser ablation produced drug particles can be preferable during the preparation of 
medicines for per os, nasal and pulmonary drug administration. Pulmonary administration of anti-inflammatory 
drugs like meloxicam or ibuprofen can be especially significant in the treatment of pneumonia or severe acute 
respiratory syndrome caused by viral infections (e.g. coronavirus). It has been shown that only sub-micrometer 
size particles can get to the lower lung area (alveolar region)25. Therefore, size-reduced drug particles produced 
by PLA may form the basis of a new type of pulmonary drug formulation for the fast and effective treatment of 
the hard-to-reach alveolar region of the lung.
Materials
Ibuprofen.  Ibuprofen (α-Methyl-4-(isobutyl) phenylacetic acid) was obtained from Sigma-Aldrich Ltd., 
(Saint Louis, Missouri, USA). It is a white powder with a particle size of 15.3 μm (d(0.5)). NSAID classification: 
Propionic acid derivatives. Thermal properties: Melting point  Tm = 75–77 °C; Boiling point  Tb = 157 °C; Degrada-
tion temperature  Tdec = 230 to 250 °C.
Meloxicam.  Meloxicam(4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-benzothiazine-3-car-boxam-
ide-1,1-dioxide) was obtained from EGIS Ltd., (Budapest, Hungary). It is a yellow powder with a particle size of 
3.78 μm (d(0.5)), 100% crystalline. NSAID classification: Enolic acid (oxicam) derivatives. Thermal properties: 
Melting point and decomposition temperature are the same,  Tm = Tdec = 254 °C.
Niflumic acid.  Conventional niflumic acid (NIF) (2-[[3-(trifluoromethyl)phenyl] amino] -3-pyridinecar-
boxylic acid) was purchased from G. Richter Pharmaceutical Factory, Budapest, Hungary. The particle size is 
18.85 μm (d(0.5)). NSAID classification: Anthranilic acid derivatives (fenamates). Thermal properties: Melting 
point and decomposition temperature are the same  Tm = Tdec = 203 °C.
Experiments
Pulsed  laser ablation  (PLA) of drug  tablets at different  laser wavelengths.  We applied three 
different laser wavelengths for pulsed laser ablation (PLA) of various drug tablets. For UV irradiation a KrF 
excimer laser (LLG Twinamp, FWHM = 18 ns, λ = 248 nm, f = 10 Hz) was used, while for VIS and IR ablation 
we applied the first and second harmonics of a Nd:YAG laser (Quantel, FWHM = 6 ns, λ = 532 nm/1064 nm, 
f = 10 Hz), respectively. We varied the number of laser pulses and adjusted the fluence from 1.5 to 12 J cm−2. In 
order to achieve a significant ablation yield, we used fluences slightly above the ablation threshold. The highest 
applied fluence was limited by the mechanical fracture of the target tablets. The tablets were produced from com-
mercially available drug powders using a hydraulic compactor at 175 MPa pressure.
Our experimental setup is shown in Fig. 1. The tablets were placed on a rotating sample holder at the bottom 
of the reaction chamber. The laser beam was focused on the target surface at a grazing angle of 45° by a fused 
silica (UV) and an N-BK7 (VIS-IR) fused silica Plano Convex lens (focal length = 17.5 cm). To be able to direct 
and control the ablated particles, we created a flow field of  N2 gas along the chamber. A constant flow rate (0.3–2 l/
min) was maintained by a T-element at the entrance of the gas jet. The ablated particles were either collected 
for chemical analysis on a filter (pore size ~ 1 μm, Merck Millipore Ltd. Omnipore Membrane Filter), or they 
directly entered the particle size analyzer at the exit of the gas stream. Theoretically, the pore size of the membrane 
filter is 1 μm, yet smaller elements can also be collected as the pores fill up with particles reaching the filter first.
Chemical  composition  characterization  methods.  Fourier transformed infrared spectroscopy 
(FTIR). The preservation of the medical effect is an essential requirement during particle size reduction in 
pharmaceutical substances. To ensure that the chemical composition of the ablated products is identical with 
that of the initial drugs, the ablated particles were analyzed by FTIR spectroscopy (Thermo Nicolet AVATAR 
330, LabX Midland, ON, Canada). The particles were collected from the filters and mixed with KBr powder for 
pellet formation. FTIR spectra were recorded in the 4000–400 cm−1 range, at a resolution of 4 cm−1, using the 
average of 128 scans.
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Raman spectroscopy. Raman spectroscopy measurements were carried out by a Thermo Scientific, DXR Raman 
microscope. Laser beam of λ = 780 nm wavelength and 1–10 mW power was used with a 0.7 μm spot size on the 
sample. We applied a 25 μm slit spectrograph aperture and 900 lines/mm grating. Raman spectra were recorded 
in the 200–1800 cm−1 range with a resolution of 5.4–8.3 cm−1. All spectra were recorded by scanning 10 times 
with a 4 s integration time.
Particle size analysis.  PLA provides an efficient way for grinding; however, the size distribution of the 
ablated particles spans a wide range, wherefore we used two types of size analyzers, having complementary, 
slightly overlapping measuring ranges.
Scanning mobility particle sizer (SMPS). We investigated the particle size distribution in the 10–800 nm range 
with SMPS (GRIMM system, Aerosol Technik, Germany, type SMPS + C). We set the scanning time to 7 min and 
repeated the measurements three times. The gas flow was 0.3 l/min during the scans.
Optical particle counter (OPC). To establish if particles larger than 800 nm were also produced, we used an OPC 
(GRIMM system, Aerosol Technik, Germany, type 1.108). OPC can reliably measure particles in the 400 nm to 
10 μm size range. We set the scanning time to 4 min and took at least 4 scans during each measurement. The gas 
flow in the equipment was 1 l/min.
Morphology studies.  Scanning electron microscopy (SEM) investigation of ablated tablet surfaces. To bet-
ter understand the particle formation mechanism during ablation, we investigated the laser treated tablet surfac-
es, the morphology of the laser irradiated areas and the backscattered particles nearby using scanning electron 
microscopy (Hitachi S-4700). Prior to imaging, the samples were sputter-coated with gold (Bio-Rad SC 502). 
SEM images were recorded at a magnification of 100 ×.
Optical  absorption  investigation.  Ellipsometry. The optical absorbance of the target material plays 
a key role in laser ablation. Since there is no relevant and reliable information about the optical absorbance 
([α] = 1/nm) of the studied drugs in the 400–1100 nm wavelength range, we determined the relevant values from 
ellipsometric data. Ellipsometric measurements were performed at different points on the tablets using a Wool-
lam M2000F rotating compensator ellipsometer. Data were collected at 75° angle of incidence, applying focusing 
optics. The ellipsometric data measured in the 250–1000 nm wavelength range could be directly transformed 
to complex refractive index values, from which the absorption coefficients were determined according to the 
α = 4*π*κ/λ expression.
Fast photography of the ablation process.  We also set up a commonly used pump and probe system 
(Fig. 2) for the visual observation of the ablation process. The pump laser was the same Nd:YAG laser (Quan-
tel, FWHM = 6 ns, λ = 532 nm/1064 nm) as for the ablation experiments. As probe lasers, we built two types 
of nitrogen laser induced dye lasers corresponding to the ablating wavelengths. In case of λablating = 1064  nm 
we used Coumarin 153 as a laser active material in the dye laser (λ = 545 nm, FWHM = 1 ns), while in case of 
λablating = 532 nm we had to change the laser active dye to Rhodamine 6G (λ = 590 nm, FWHM = 1 ns) in order to 
avoid an overlap between the pump and probe signals. The dye laser beams were transported to the experimental 
field by an optical fiber and collimated with an N-BK7 focusing lens (f = 15 cm). A CCD camera (The Imaging 
Figure 1.  Experimental setup.
4Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:15806  | https://doi.org/10.1038/s41598-020-72865-z
www.nature.com/scientificreports/
Source-DMK 23G445, 30 fps, N = 3 ×) was placed opposite the optical fiber. To filter out the white light of the 
generated plasma, we applied a bandpass optical filter in front of the camera. The central and controlling element 
of this setup was the digital delay generator (DDG) (SRS-DG645), which can separately trigger the pump and the 
probe lasers and the camera with a delay time in the nanosecond to millisecond range.
Results
Infrared spectroscopy (FTIR) of ablated drug particles.  FTIR spectra obtained from the collected 
particles are shown in Fig. 3a. Some contamination of the sample was inevitable while the collected particles 
were scraped or peeled off the filter. Therefore, we subtracted the FTIR spectrum of pure Millipore filter as back-
ground spectrum. The two peaks between 2250 and 2500 cm−1 are related to the  H2O and  CO2 content of the 
samples and give no relevant information for this investigation.
FTIR spectra of ibuprofen particles generated at different wavelengths and fluences are shown in Fig. 3. It can 
be seen that all laser fluences applied at the UV wavelength (248 nm) caused significant chemical damage to the 
particles. However, the persisting characteristic peaks of ibuprofen [e.g. 1720 cm−1 (H-bonded C=O); 1231 cm−1 
(H-bonded CO–H); 780 cm−1 (C=O)]26 in the FTIR spectra indicate that no chemical changes occurred at VIS 
(532 nm) and IR (1064 nm) wavelengths. We had similar observations in the case of niflumic acid [e.g. 1668 cm−1 
(C–O); 1614 cm−1 (benzene ring); 1428 cm−1 (C=O/OH); 1110 cm−1 (C–F)]27,28 and meloxicam [e.g. 1620 cm−1 
(N–H); 1550 cm−1 (thiazole ring); 1346 and 1264 cm−1 (sulfone)]29,30 (Fig. 4). During IR ablation of niflumic acid, 
4.5 J cm−2 and 6 J cm−2 laser fluences yielded a sufficient amount of particles for FTIR analysis.
Since we wanted to avoid chemical modification of the pharmaceutical compounds, we used only VIS and 
IR wavelengths for further investigations.
Figure 2.  Pump and probe setup for fast photography.
Figure 3.  FTIR spectra of the produced ibuprofen particles; (a) measured spectrum of collected particles 
(black), background spectrum of filter (green), background-subtracted spectrum of particles (red); (b) 
background-subtracted FTIR spectra of ibuprofen particles prepared at different wavelengths and fluences.
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Figure 4.  FTIR spectra of drug particles produced by laser ablation at different wavelengths and laser fluences; 
(a) niflumic acid; (b) meloxicam.
Figure 5.  Raman spectra of drug particles produced by laser ablation at different wavelengths and at the highest 
applied laser fluences; (a) ibuprofen; (b) niflumic acid; (c) meloxicam.
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Raman spectroscopy of generated drug particles.  We recorded several spectra at different places 
from each ablation product to obtain information about their homogeneity. For simplicity, in Fig. 5, only those 
spectra are compared with the original pharmaceuticals’ spectra that were recorded from the particles ablated 
by the highest laser fluences (i.e., may have suffered the most severe chemical changes) at both wavelengths. We 
marked some characteristic bands of ibuprofen (477, 833 and 1608 cm−1) (Fig. 5a), niflumic acid (999, 1210 and 
1605 cm−1) (Fig. 5b) and meloxicam (1302, 1540 and 1595 cm−1) (Fig. 5c), and found no discrepancies in the 
spectra of the original drugs and their ablation products produced at 532 and 1064 nm.
Particle  size analysis.  Using both SMPS and OPC, we investigated the size distribution of the ablated 
particles in a very wide range, from 10 nm to 10 μm. For each fluence, the repetition rates of the laser shots were 
adjusted to prevent the suction tube from getting clogged by ablated particles. During evaluation, we normalized 
the particle numbers to 1 Hz repetition rate for data comparison.
Size distribution (measured by SMPS) of ibuprofen particles produced by laser ablation at 532 nm and 
1064 nm wavelengths can be seen in Fig. 6. The mode values in both distributions were below 100 nm. The abla-
tion yield of niflumic acid was considerably higher than for ibuprofen, especially at 532 nm (Fig. 7). The broadest 
size distributions with the highest mode values were obtained for the ablated meloxicam particles (Fig. 8); the 
full widths at half maximums (FWHMs) of the distributions ranged from 300 to 400 nm and the mode values 
for higher fluences exceeded 200 nm. We fitted one or more lognormal curves to the measurements. In case of 
high ablation yields data could be fitted to a single curve, while we had to cumulate two or more curves for small 
amounts of ablated particles.
Figure 6.  Size distribution of ibuprofen particles produced by laser ablation (a) at λ = 532 nm with 3 J cm−2 
(black), 6 J cm−2 (red) and 9 J cm−2 (green) fluences; (b) at λ = 1064 nm with 6 J cm−2 (black), 9 J cm−2 (red) and 
12 J cm−2 (green) fluences.
Figure 7.  Size distribution of niflumic acid particles produced by laser ablation (a) at λ = 532 nm with 1.5 J cm−2 
(black), 3 J cm−2 (red) and 6 J cm−2 (green) fluences; (b) at λ = 1064 nm with 3 J cm−2 (black), 4.5 J cm−2 (red), 
6 J cm−2 (green) fluences.
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All measurements above were also repeated with the OPC system to see if particles larger than 800 nm were 
also produced. Since OPC uses a higher gas flow than SMPS, the number of particles had to be normalized to 
the flow rate of SMPS and 1 Hz repetition rate. It must be noted that the two systems give different size values 
due to the different detection mechanisms (SMPS—by electrical mobility; OPC—by optical scattering). Hence 
the differences between them are minor and the values are mainly the  same31. We did not find many particles 
larger than 800 nm in either case. Figure 9 shows the particle size distributions obtained by both SMPS and OPC 
for the ablation of niflumic acid. We chose this plot to demonstrate a common overlap of the distributions. The 
overlaps are the same for the other ablating parameters too.
The main experimental results are summarized in Table 1. There is no sign of clear relationship between laser 
fluences and size distributions in the investigated fluence range. However, we can establish that the number of 
ablated drug particles grows with the applied fluence at any wavelength. The growth in ablated particles can 
clearly be seen at λ = 532 nm ablation. In case of ibuprofen and niflumic acid, the most abundant particles are 
smaller at IR ablation than at VIS with equivalent fluences. In the case of meloxicam, there were no overlaps in 
the fluence values due to different ablating outcomes (thresholds, cracks). Nevertheless, we can still claim that 
at higher laser fluences the modes of meloxicam particle size distributions belong to the same size range for IR 
and VIS wavelengths. It can be clearly stated that in any case the efficiency of ablation (i.e. the number of ablated 
particles) is the highest for meloxicam, slightly lower for niflumic acid, while it is the lowest for ibuprofen.
SEM investigation of ablated surfaces.  SEM images taken from the intact and ablated drug tablet sur-
faces are shown in Fig. 10. Laser irradiations at VIS and IR wavelengths resulted in similar surface structures: 
Figure 8.  Size distribution of meloxicam particles produced by laser ablation (a) at λ = 532 nm with 1.5 J cm−2 
(black), 3 J cm−2 (red) and 6 J cm−2 (green); (b) at λ = 1064 nm with 9 J cm−2 (black), 12 J cm−2 (red) and 
15 J cm−2 (green).
Figure 9.  Size distributions obtained by SMPS and OPC for the same ablation parameters. The plots 
demonstrate a common overlap of the distributions.
8Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:15806  | https://doi.org/10.1038/s41598-020-72865-z
www.nature.com/scientificreports/
crystal layers with sharp edges and cracks prevailed, and no smooth or melted areas could be found. This sup-
ports the observation that unmodified drug molecules can be produced by the PLA method.
Ellipsometry.  Absorption spectra of the investigated drugs were recorded in a wide optical range, from 
ultraviolet to near infrared. The smallest absorption coefficients were obtained in the IR, while the biggest ones 
in the UV range (Fig. 11). The increased absorption in the UV is most noticeable for meloxicam and niflumic 
acid. This is in accordance with our observation that drug molecules degrade during ablation by UV light. 
Table 1.  General information on the size distribution of ablated drug particles. F fluence, d diameter, FWHM 
full width at half maximum, Nmax number of particles at peaks of distribution.
F (J cm−2) D (nm) FWHM (nm) Nmax F (J cm−2) D (nm) FWHM (nm) Nmax
Ibuprofen 532 nm Ibuprofen 1064 nm
3 62 17 281 6 42.75 12 0.61
6 56.4 61 545 9 39 16 25
9 56.7 33 5131 12 82.2 84 472
Niflumic acid 532 nm Niflumic acid 1064 nm
1.5 123.71 97 2218 3 62 17.6 50
3 153 151 9590 6 62 45 166
6 137 123 179,400 9 101 37 795
Meloxicam 532 nm Meloxicam 1064 nm
1.5 100.89 101 115 9 170.49 297 414
3 213 234 4739 12 213 362 2374
6 240 300 259,158 15 240 372 25,306
Figure 10.  SEM images of intact and ablated surfaces of drug tablets; (A) intact ibuprofen surface, (B) ablated 
at 532 nm, (C) ablated at 1064 nm, (D) intact niflumic acid surface, (E) ablated at 532 nm, (F) ablated at 
1064 nm, (G) intact meloxicam surface, (H) ablated at 532 nm, (I) ablated at 1064 nm.
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Optical absorption of ibuprofen has only been observed at around 250 nm32. This wavelength falls outside our 
measurement range (260–1000 nm), therefore we could not detect it.
We estimated the laser induced temperature rise at different depths in the target drugs by simple model calcu-
lations in which we varied the laser wavelength and fluence for each drug. Ignoring heat conduction, we applied 
the Beer–Lambert law (Eq. 1) to calculate the temperature change at the surface and at the penetration depths:
where α is the wavelength dependent absorption coefficient, x is the distance from the surface, F is the applied 
fluence of the laser beam, ρ is the density and c is the specific heat of the target material. We used the mean 
specific heat values between room temperature and the decomposition temperatures of the drugs in the absence 
of reliable data in the literature and since c is temperature dependent. We also calculated the reflexivity of the 
drugs for different incident angles and polarizations. Since reflexivity was under 10% for all wavelengths, we 
neglected it in the calculations. The parameters and the calculated penetration depths (d = 1/α) are summarized 
in Table 2. In all three medicines the highest temperatures occur at the UV wavelength. The temperature values 
are close at VIS and IR wavelengths, hence the differences between the absorption coefficient values are minor. 
At these two wavelengths, during ibuprofen ablation the estimated temperatures (depending on the fluences) 
exceed several thousand kelvins (2000–10,000 K) at the surface where the temperature values are the highest. 
This is followed in magnitude by meloxicam, where these values are higher and reach 10,000–20,000 K. Surface 
temperatures are the highest in niflumic acid, where these values reach 30,000–100,000 K. The temperatures 
at the laser penetration depths always significantly exceed the decomposition temperatures of the materials. 
Therefore, chemically preserved particles cannot originate from the volume element  (Ve)—defined by the laser 
spot size and penetration depth  (Ve = Aspot*d)—and these particles must be produced by another mechanism.
Fast photography.  Successive stages of the ablation process were captured by fast photography. This infor-
mation is valuable for us in representing and understanding the dynamics of particle generation. Figure  12 
shows fast photography images deemed essential for the important stages of particle generation.
It can be clearly seen that the ablation mechanism is the same for all three studied drugs. The generated shock 
wave is closely followed by a cloud of non-condensed state of matter expanding at a slightly lower speed than 
the shock front. After that, solid particles increasing in size with time start to exit the surface, which means that 
bigger and heavier particles have lower velocities. It can be easily observed that particles of all sizes were gener-
ated during the ablation of drug tablets, although we could not detect a sufficient number of particles above 1 μm 
with the particle sizer methods. This can be explained with the mass dependence of the mean free path and the 
phenomenon that the magnitude of gas flow limits the sizes of transportable particles.
(1)�T(x) =
α ∗ F
ρ ∗ c
∗ e
−αx
Figure 11.  Absorption coefficients of meloxicam (black), niflumic acid (red), and ibuprofen (blue).
Table 2.  Input data for temperature calculations; d (1/α)-optical penetration depth.
ρ (kg*m−3) c (J/(K*kg))
λ = 260 nm λ = 532 nm λ = 1000 nm λ = 260 nm λ = 532 nm λ = 1000 nm
α (1/μm) α (1/μm) α (1/μm) d (nm) d (nm) d (nm)
Ibuprofen 1030 1553 0.514 0.2 0.305 1940 5000 3280
Nifl. acid 1400 2000 10 3 1.6 100 333 625
Meloxicam 1614 1800 14 1 0.407 71.42 1000 2146
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To estimate the significance of photomechanical effects during ablation, we calculated the pressures pro-
duced in the target material at the shock  fronts33. First we calculated the propagation velocity of the shock front 
by measuring its travel distance as a function of time, and then the pressure was estimated according to Eq. 2:
where P is the pressure produced at the shock front, ρ is the density of the medium, v is the velocity of the shock 
front and γ is the proportion of specific heats  (cp/cV) of the medium. In Fig. 13 some examples of the calculated 
pressures are shown. The recoil pressures—which are equivalent with the initial pressures at the shock front—are 
70–350 atm. These relatively high pressure values confirm our assumption, that the photomechanical effects have 
a significant contribution to the ablation process.
Discussion
In the course of PLA, two successive and significantly different material ejection mechanisms can be distin-
guished: (I) Prompt evaporation of the target material directly from the center of the focused laser beam spot, 
where very high temperatures are created close to the surface. (II) Material ejection induced by the photome-
chanical effect due to pressure pulse and shock wave formation in the bulk material as a result of fast evapora-
tion. According to our approximate calculations, temperatures as high as  103 K to  104 K can be created at the 
(2)P =
2
γ + 1
∗ ρ ∗ v2,
Figure 12.  Fast photography images of drug ablations.
Figure 13.  Pressure calculations for the shock fronts in case of (a) ibuprofen with 9 J cm−2; (b) niflumic acid 
with 6 J cm−2 and (c) meloxicam 6 J cm−2, λ = 532 nm.
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target surface. Some of the imparted energy is transferred inside the target material by heat conduction, and in 
the volume element  (Ve) the temperature exceeds a critical value and fast vaporization processes occur with the 
formation of high-pressure ionized plasma. In this nonequilibrium plasma micro-explosions take place, and the 
pressure pulse initiates the propagation of a high velocity shock wave outwards from the excited volume element. 
Then vaporized and highly decomposed products burst out as shown in Fig. 12A. However, a major part of the 
target material is ejected via photomechanical processes. The shock wave induced recoil forces and mechani-
cal stresses result in the ejection of small and large fractures from the surface. The photomechanical ablation 
mechanism is more significant in case of nanosecond laser  pulses17. The fractured particles leave the target at 
different velocities in accordance with their size and mass. This is in good agreement with our fast photography 
results (Fig. 12) where submicron sized particle ejection occurs at nanosecond and few microsecond time scales. 
Larger, micron-sized and irregularly shaped particles are ejected in the microsecond  scale16–19.
The above observations apply mainly to homogeneous bulk materials. In case of drug tablets where the tar-
gets are highly porous and consist of micrometer-sized grains, the PLA process is slightly different. The uneven 
surface of the ablation holes, which can be clearly seen in the SEM images (Fig. 10) and the pressure calcula-
tions in indicate strong photomechanical effects. Thus, the subsequent laser pulses reach irregularly shaped 
target surfaces. The effect of target inhomogeneity is pictured in Fig. 12, as multiple shock waves are developing 
after one laser pulse. Consequently, the ideal homogenous optical absorption mechanism does not hold for our 
porous drug tablet targets, where lower temperature changes and photomechanical effects occur. Furthermore, 
since the drug grains are more loosely bound together in compacted tablets than in a bulk material, much higher 
ablation yields can be attained. Occasionally the recoil forces rip out large pieces (several microns in diameter) 
from the tablets. These phenomena explain the random fluence dependency in the size distribution of the ejected 
particles (Table 1). In bulk materials, the average size of the ablated particles and the FWHMs of the particles’ 
size distribution increase with the  fluence34,35.
According to the FTIR investigations, PLA at UV (λ = 248 nm) laser wavelength is not an adequate method 
for creating chemically preserved particles. This conclusion is supported by the high absorption coefficients of 
drugs measured in the UV regime (see Fig. 11). Our calculations, which were based on the absorption coef-
ficients, show that the UV laser beam creates the highest temperature in the excited volume element, and it has 
the lowest penetration depth in the target material (see Table 2). Therefore, the secondary photomechanical 
effects, which can lead to the ejection of chemically non-degraded particles, are less significant. Moreover, the 
energy of the photons  (Ep(λ = 248 nm) = 5 eV) exceeds the energy of several chemical bonds in the drug mol-
ecules, enhancing the probability of direct photochemical reactions like photolysis or photo dissociation. We 
concluded that by PLA at λ = 248 nm, the ejected particles consist mainly of degraded drug molecules, similarly 
to polymers seen  before36–38.
At higher wavelengths, i.e. at lower photon energies  [Ep(λ = 532 nm) = 2.33 eV;  Ep(λ = 1064 nm) = 1.16 eV], 
the photochemical effects are less significant, but at the same time more drastic photomechanical effects can be 
expected. Due to the lower temperatures induced in the target material and the larger penetration depths of the 
VIS/IR laser beams, the secondary material ejection mechanisms are more prominent at 532 nm and 1064 nm 
laser wavelengths. This allows for the production of chemically preserved drug  particles39. With the use of a laser 
beam at 532 nm considerably higher ablation yields could be achieved even at lower fluences than at 1064 nm 
(Table 1). This can be related to the higher (but still moderate) absorption coefficient at 532 nm. According to 
our observations, at 1064 nm laser wavelength the mechanical degradation (photo disruption) of the tablets 
was so severe that the tablets rapidly broke into pieces, greatly decreasing the ablation lifetime and ablation 
yield. A more elaborate evaluation of the ablation yields requires the consideration of the thermal and mechani-
cal characteristics of the target materials too. It has been shown that there is a strong relationship between the 
mechanical properties (density, mechanical hardness) of the target and the ablation  yield40. We suspect that the 
mechanical properties of the drug tablets influenced our experiments too. This can explain our observation that 
the ablation yields are higher for meloxicam than for niflumic acid although meloxicam’s absorption coefficients 
are lower at both wavelengths.
We must make two additional remarks. One concerns the absence of absorption bands in the FTIR spectra, 
which can be related to the degraded molecules. We suppose that at temperatures of thousands of kelvins in the 
evaporation zone the material is practically atomized/ionized, and therefore cannot be filtered out from the gas 
jet. This means that if there are any chemically modified but not completely atomized molecules, they must rep-
resent a negligible proportion of the whole ablation mass. Our other comment is that during the size distribution 
measurements (Fig. 9) no particles above ~ 1 μm in diameter were detected, although the formation of bigger 
particles can evidently be seen in the fast photography pictures (Fig. 12). Most probably, these bigger and heavier 
particles simply fell back to the surface, since even the highest adjustable gas flow was unable to transport them.
conclusion
PLA can be applied for the size reduction of poorly water-soluble NSAIDs. In the case of meloxicam, ibupro-
fen and niflumic acid, submicron to nanometer size particles can be produced by careful selection of the laser 
parameters, reducing the initial mean average sizes by orders of magnitude.
We have found that ablation without any chemical destruction of the initial pharmaceutical compounds can 
only be performed with laser beams having wavelengths in the VIS and IR range. Higher ablation yields are 
obtained at 532 nm than at 1064 nm laser wavelength, and the yields are generally increasing with the applied 
fluence for the studied drugs. Without aiming to conduct a thorough investigation we could also establish the 
influence of the absorption coefficients and the structure of the target drug tablets on the ablation mechanism.
The SMPS/OPC measurements provided particle size data precisely from that fraction of the laser ablated 
aerosol which can be pumped through a nasal delivery device and inhaled by the patient.
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We concluded that PLA offers a chemical-free, verifiably reproducible and simple method for the size reduc-
tion of poorly water-soluble drug crystallites. The achieved submicron size range can be especially advantageous 
for the development of new pulmonary drug formulations for the medication of the lower lung area in pneumonia 
or severe acute respiratory syndrome. The adjustable laser parameters and thereby the fine tuning of the grind-
ing mechanism during PLA can be advantageous over other commonly used methods when formulating drug 
delivery systems for sensitive compounds.
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